Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Shareholders??? Equity

v3.24.1
Consolidated Statements of Shareholders’ Equity - USD ($)
$ in Thousands
Ordinary shares
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total
Balance at Dec. 31, 2020 $ 2,933 $ 75,547 $ (969) $ (73,034) $ 4,477
Balance (in Shares) at Dec. 31, 2020 6,963,838        
Issuance of ordinary shares and warrants, net of issuance costs $ 1,035 31,758 32,793
Issuance of ordinary shares and warrants, net of issuance costs (in Shares) 2,250,000        
Exercise of warrants $ 665 5,053 5,718
Exercise of warrants (in Shares) 1,442,149        
Exercise of options $ 31 268 299
Exercise of options (in Shares) 66,037        
Share-based compensation 1,597 1,597
Net income (loss) 237 237
Balance at Dec. 31, 2021 $ 4,664 114,223 (969) (72,797) 45,121
Balance (in Shares) at Dec. 31, 2021 10,722,024        
Exercise of warrants $ 191 1,509 1,700
Exercise of warrants (in Shares) 425,000        
Exercise of options $ 18 156 174
Exercise of options (in Shares) 39,457        
Share-based compensation 2,211 2,211
Net income (loss) (16,925) (16,925)
Balance at Dec. 31, 2022 $ 4,873 118,099 (969) (89,722) $ 32,281
Balance (in Shares) at Dec. 31, 2022 11,186,481       11,186,481
Exercise of warrants $ 76 668 $ 744
Exercise of warrants (in Shares) 186,000        
Exercise of options $ 33 331 $ 364
Exercise of options (in Shares) 80,191       76,441
Share-based compensation 1,970 $ 1,970
Net income (loss) (7,019) (7,019)
Balance at Dec. 31, 2023 $ 4,982 $ 121,068 $ (969) $ (96,741) $ 28,340
Balance (in Shares) at Dec. 31, 2023 11,452,672       11,452,672